Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory Effects of Adoair in Japanese COPD Patients
NCT01607398Phase 4Completed
- Sponsor
- GSK
- Start
- May 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started May 2012; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01607398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607398.